Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP775314.RAOniLCNfQIrxx-xM82ugohmiAN7H02I4Nb8aA8zmcxHk130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP775314.RAOniLCNfQIrxx-xM82ugohmiAN7H02I4Nb8aA8zmcxHk130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP775314.RAOniLCNfQIrxx-xM82ugohmiAN7H02I4Nb8aA8zmcxHk130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP775314.RAOniLCNfQIrxx-xM82ugohmiAN7H02I4Nb8aA8zmcxHk130_provenance.
- NP775314.RAOniLCNfQIrxx-xM82ugohmiAN7H02I4Nb8aA8zmcxHk130_assertion description "[Finally, the study of associations between critical clinicopathological parameters and activated DDR factors highlighted a statistically meaningful correlation between reduced local tumor extension and the phosphorylation of ATM, CHK2 and the presence of 53BP1, whereas no significant correlations with parameters such as survival or relapse of early-stage lung carcinomas were found.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775314.RAOniLCNfQIrxx-xM82ugohmiAN7H02I4Nb8aA8zmcxHk130_provenance.
- NP775314.RAOniLCNfQIrxx-xM82ugohmiAN7H02I4Nb8aA8zmcxHk130_assertion evidence source_evidence_literature NP775314.RAOniLCNfQIrxx-xM82ugohmiAN7H02I4Nb8aA8zmcxHk130_provenance.
- NP775314.RAOniLCNfQIrxx-xM82ugohmiAN7H02I4Nb8aA8zmcxHk130_assertion SIO_000772 17522062 NP775314.RAOniLCNfQIrxx-xM82ugohmiAN7H02I4Nb8aA8zmcxHk130_provenance.
- NP775314.RAOniLCNfQIrxx-xM82ugohmiAN7H02I4Nb8aA8zmcxHk130_assertion wasDerivedFrom befree-20140225 NP775314.RAOniLCNfQIrxx-xM82ugohmiAN7H02I4Nb8aA8zmcxHk130_provenance.
- NP775314.RAOniLCNfQIrxx-xM82ugohmiAN7H02I4Nb8aA8zmcxHk130_assertion wasGeneratedBy ECO_0000203 NP775314.RAOniLCNfQIrxx-xM82ugohmiAN7H02I4Nb8aA8zmcxHk130_provenance.
- befree-20140225 importedOn "2014-02-25" NP775314.RAOniLCNfQIrxx-xM82ugohmiAN7H02I4Nb8aA8zmcxHk130_provenance.